Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Allwood MC, Stonkute D, Wallace A, Wilkinson AS, Hills T, Jamieson C; BSAC Drug Stability Working Party. Allwood MC, et al. Among authors: jamieson c. Eur J Hosp Pharm. 2020 Mar;27(2):90-94. doi: 10.1136/ejhpharm-2018-001515. Epub 2018 Sep 18. Eur J Hosp Pharm. 2020. PMID: 32153771 Free PMC article.
Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting.
Jamieson C, Allwood MC, Stonkute D, Wallace A, Wilkinson AS, Hills T; BSAC Drug Stability Working Party. Jamieson C, et al. Eur J Hosp Pharm. 2020 Mar;27(e1):e53-e57. doi: 10.1136/ejhpharm-2018-001699. Epub 2019 Jan 13. Eur J Hosp Pharm. 2020. PMID: 32296506 Free PMC article.
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.
Jamieson C, Ozolina L, Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS; BSAC Drug Stability Testing Working Group. Jamieson C, et al. Eur J Hosp Pharm. 2022 Jul;29(4):212-216. doi: 10.1136/ejhpharm-2020-002340. Epub 2020 Sep 25. Eur J Hosp Pharm. 2022. PMID: 32978220 Free PMC article.
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document.
Sime FB, Wallis S, Jamieson C, Hills T, Gilchrist M, Santillo M, Seaton RA, Drummond F, Roberts J; BSAC Drug Stability Testing Programme. Sime FB, et al. Among authors: jamieson c. Eur J Hosp Pharm. 2023 Mar;30(e1):e76-e81. doi: 10.1136/ejhpharm-2022-003286. Epub 2022 May 24. Eur J Hosp Pharm. 2023. PMID: 35609967 Free PMC article.
Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT).
Gilchrist M, Jamieson C, Drummond F, Hills T, Seaton RA, Santillo M. Gilchrist M, et al. Among authors: jamieson c. JAC Antimicrob Resist. 2023 Apr 17;5(2):dlad047. doi: 10.1093/jacamr/dlad047. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 37077650 Free PMC article. No abstract available.
497 results